Previous 10 | Next 10 |
This year, investors flocked to companies trying to solve two of today's biggest health problems: COVID-19 and cancer. Players in these fields took the three top spots in 2020 biotech share performance, each surging more than 1,000%. In fact, they weren't only the best performers in biotech...
Investors have awarded Vaxart (NASDAQ: VXRT) for its innovation this year. Like more than 50 other companies, Vaxart is developing a potential coronavirus vaccine. But its vaccine doesn't involve a jab; it's a tablet to be taken orally. Shares rose as the company announced its devel...
Are These The Best Biotech Stocks To Buy In December 2020? Biotech stocks have been all the rage in the stock market this year. This came as a number of companies have aspired to end the coronavirus pandemic. Now, as Pfizer ( PFE Stock Report ) and BioNTech ( BNTX Stoc...
After Pfizer / BioNTech, Moderna and AstraZeneca released their interim data from COVID-19 vaccine trials, many might think the market would be saturated with vaccine developer news. However, laws of supply and demand dictate that all developers that have showed signs of efficacy or a...
The following slide deck was published by Vaxart, Inc. in conjunction with this event. For further details see: Vaxart (VXRT) Investor Presentation - Slideshow
Even for people who like to bet on the underdog, it doesn't make much sense to place a bet after the race is over. Now that Moderna and Pfizer have both announced that their coronavirus vaccine candidates appear to be effective at preventing infection, distant laggards look less des...
Healthcare stocks have a rich history of churning out big winners. The sector has been a hotbed of innovation over the past decade, leading to breakthrough treatments for a variety of hard-to-treat cancers, rare diseases, and chronic illnesses like arthritis and diabetes, among many others....
FinancialBuzz.com News Commentary New York, NY (11/23/2020) – Biotechnology and pharmaceutical companies are now very close to an effective vaccine to fight the current pandemic. Earlier this month, Pfizer and BioNTech SE announced that their vaccine candidate was found to be mor...
FinancialBuzz.com News Commentary New York, NY (11/16/2020) – New restrictions are being implemented in several states across the country as the number of those infected with COVID-19 is once again on the rise. For instance, New York City’s new restrictions went in...
Title: An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus Key topics: COVID-19: Immunity & Immunological Memory Norovirus: Disease Burden & Prevention. The Current Status of Vaccine Development ...
News, Short Squeeze, Breakout and More Instantly...
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2024 after the market close on Thursd...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...